SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Olaparib-Abiraterone in mCRPCs Selected by Biomarkers Outperforms Each Agent by Itself.

2.

Talk About Medication Costs, Bringing Back Touch, and Understanding From Dish Tumors.

3.

Taking Charge of Your Cancer Journey.

4.

Patellar Resurfacing in Total Knee Replacement; Patient Messaging Trends

5.

Silibinin is a novel and ancient molecule that highlights the significance of integrated therapies for cancer.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot